Bioteque Corporation (TPEX: 4107)

Market Cap	8.84B
Revenue (ttm)	2.09B
Net Income (ttm)	499.22M
Shares Out	69.30M
EPS (ttm)	7.17
PE Ratio	17.78
Forward PE	16.95
Dividend	4.50 (3.56%)
Ex-Dividend Date	Jul 30, 2024

Volume	123,889
Open	125.50
Previous Close	126.00
Day's Range	125.50 - 128.00
52-Week Range	106.00 - 147.50
Beta	0.46
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 11, 2024

About Bioteque

Bioteque Corporation manufactures and sells medical devices in Asia, South America, North America, and internationally. The company provides medical disposables for use in hemodialysis access, endovascular treatment, and other fields. It offers dialysis products, including hemodialysis bloodlines, A.V.F. needles, and hemodialysis cathers; interventional radiology products, such as pigtail drainage catheter sets, introducer sets, connecting tubes, drainage bags, and radiopaque dilators; urology products comprising ureteral stent sets and urine c...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1991
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4107

Financial Performance

In 2023, Bioteque's revenue was 1.94 billion, a decrease of -3.26% compared to the previous year's 2.01 billion. Earnings were 452.55 million, a decrease of -8.31%.